Development of vaccines at the time of COVID-19

Author:

Almond Jeffrey1,Hacker Jörg2,Harwood Colin3,Pizza Mariagrazia4,Rappuoli Rino4,Ron Eliora Z5ORCID,Sansonetti Philippe6,Vanderslott Samantha7,Wieler Lothar H8

Affiliation:

1. The Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK

2. German National Academy of Science Leopoldina, Jägerberg 1, 06108 Halle, Germany

3. Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne NE2 4AX, UK

4. GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy

5. The Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, PO Box 39040, Tel Aviv 6997801, Israel

6. Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France

7. Oxford Vaccine Group and Oxford Martin School, 34 Broad St, Oxford OX1 3BD, UK

8. Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany

Abstract

ABSTRACT In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Reference70 articles.

1. Adjuvants: classification, modus operandi, and licensing;Apostolico Jde;J Immunol Res,2016

2. Louis Pasteur (1822–1895);Bardenave;Microbes Infect,2003

3. A tale of two bacterial enteropathogens and one multivalent vaccine;Barry;Cell Microbiol,2019

4. Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren;Behring;Dtsch Med Wschr,1890

5. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs;Berti;Curr Opin Immunol,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3